Novo Nordisk A/S ADR (NVO)

Feb 21, 2025, 11:12 AM EST - 1 day ago

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Feb 20, 2025, 1:31 PM EST - 2 days ago

Investors in Novo Nordisk A/S Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights – NVO

Feb 20, 2025, 4:47 AM EST - 2 days ago

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Feb 19, 2025, 11:59 PM EST - 2 days ago

Why Novo Nordisk Is A Strong Buy Despite Market Concerns

Feb 19, 2025, 11:08 AM EST - 3 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 19, 2025, 8:00 AM EST - 3 days ago

A Rip Van Winkle Portfolio: Invest In These Companies And Forget You Did It

BABA GIS GOOG GOOGL META PEP

Feb 18, 2025, 9:26 AM EST - 4 days ago

Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences

Feb 13, 2025, 8:15 AM EST - 9 days ago

Novo Nordisk: Dips Like These Come Once Every Few Years

Feb 12, 2025, 4:40 PM EST - 10 days ago

Ozempic shows some promise for alcohol use disorder

Feb 12, 2025, 12:40 PM EST - 10 days ago

Ozempic's Active Ingredient May Reduce Alcohol Cravings, Study Says

Feb 12, 2025, 11:01 AM EST - 10 days ago

Popular weight-loss drug helps to reduce alcohol consumption and smoking, new study finds

Feb 10, 2025, 3:30 PM EST - 12 days ago

MoneyShow's Best Investment Ideas For 2025: Part 10

AMD CIG ETSY IPX LYG NKE

Feb 10, 2025, 9:50 AM EST - 12 days ago

Is Novo Nordisk's Bottom Here? Oversold Status Below 10Y P/E Lows

Feb 9, 2025, 1:00 AM EST - 13 days ago

Novo Nordisk: 2024 Earnings Review

Feb 7, 2025, 7:54 AM EST - 15 days ago

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Feb 7, 2025, 2:45 AM EST - 15 days ago

Novo Nordisk A/S: Once-weekly Mim8 is well-tolerated and efficacious in children living with haemophilia A with and without inhibitors

Feb 6, 2025, 6:27 PM EST - 16 days ago

Final Trade: UPST, MTCH, NVO, C

C MTCH UPST

Feb 5, 2025, 3:15 PM EST - 17 days ago

Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs

Feb 5, 2025, 2:40 PM EST - 17 days ago

Novo Nordisk CEO expects same growth for 2025

Feb 5, 2025, 1:58 PM EST - 17 days ago

Novo Nordisk Has Probably Declined Enough

Feb 5, 2025, 1:30 PM EST - 17 days ago

Novo Nordisk CEO shares his outlook for Wegovy pricing in the U.S.

Feb 5, 2025, 11:45 AM EST - 17 days ago

Novo Nordisk: Among The Best Opportunities Of The Moment (Rating Upgrade)

Feb 5, 2025, 11:13 AM EST - 17 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Feb 5, 2025, 10:15 AM EST - 17 days ago

UBER's Autonomous Uncertainty, CMG Slips & NVO Rises on Earnings

UBER CMG

Feb 5, 2025, 10:13 AM EST - 17 days ago

Novo Nordisk Q4 Earnings: Outperformance Suggests Stock Price Comeback Starts Today

Feb 5, 2025, 10:00 AM EST - 17 days ago

Novo Nordisk CEO says firm's obesity pill could launch before Eli Lilly

Feb 5, 2025, 9:33 AM EST - 17 days ago

Amid Novo Nordisk's Win for Ozempic's Expanded Label to Include Chronic Kidney Disease Benefits, Spherix Global Insights Highlights Nephrologists' Rising Influence in GLP-1 RA Utilization

Feb 5, 2025, 9:14 AM EST - 17 days ago

Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook